WASHINGTON, Aug. 21 The Advisory Board Company (Nasdaq: ABCO) announced today that Robert W. Musslewhite, Chief Executive Officer, and Michael T. Kirshbaum, Chief Financial Officer are scheduled for presentations at three upcoming investor conferences.
Mr. Musslewhite and Mr. Kirshbaum are scheduled to present on Wednesday, September 9, 2009 at 12:45 PM at the Robert W. Baird & Co. Health Care Conference in New York, New York.
Mr. Musslewhite and Mr. Kirshbaum are scheduled to present on Wednesday, September 23, 2009 at 12:00 PM at the UBS Global Life Sciences Conference in New York, New York.
Mr. Musslewhite and Mr. Kirshbaum are scheduled to present on Tuesday, October 6, 2009 at 4:15 PM at the William Blair & Company Emerging Growth Stock Conference in New York, New York.
The presentation materials will be available on the Company's website, found at http://www.advisoryboardcompany.com, through October 20, 2009.
About The Advisory Board Company
The Advisory Board Company provides best practices research, analysis, executive education and leadership development, business intelligence tools, and installation support services primarily to the health care industry, focusing on business strategy, operations, and general management issues. The Company provides best practices and research through discrete programs to a membership of approximately 2,800 organizations, including leading hospitals, health systems, pharmaceutical and biotech companies, health care insurers, medical device companies, colleges, universities, and other education institutions. Members of each program are typically charged a fixed annual fee and have access to an integrated set of services that may include best practice research studies, executive education seminars, customized research briefs, web-based access to the program's content database, and business intelligence tools.
SOURCE The Advisory Board Company